Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06915441 · ClinicalTrials.gov registry record · Phase 2
Lipid Infusions to Optimize Nutrition Trial
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 230
- Enrollment target
NCT06915441 is a Phase 2 study that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 230 participants.
The verdict
NCT06915441, a Phase 2 study, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 230 participants
- Enrollment target
Study Summary
The purpose of this study is to identify survival free of bronchopulmonary dysplasia (BPD), fatty acid profiles, and early biochemical measures for oxidative stress comparing mixed oil lipid emulsion (MOLE) vs soybean oil-based lipid emulsion (SOLE) and to establish whether MOLE or SOLE is more effective in minimizing pulmonary outcomes, neonatal morbidities, long-term morbidity and mortality, and improving discharge growth and Bayley Scales of Infant Development Fourth Edition (BSID-IV) neurodevelopmental assessment at two years
Interventions
- DRUG SOLE
- DRUG MOLE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2030-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06915441
The ClinicalTrials.gov registry entry for NCT06915441 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SOLE is the first listed.
NCT06915441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06915441 about?
NCT06915441 is a clinical study titled "Lipid Infusions to Optimize Nutrition Trial". The purpose of this study is to identify survival free of bronchopulmonary dysplasia (BPD), fatty acid profiles, and early biochemical measures for oxidative stress comparing mixed oil lipid emulsion (MOLE) vs soybean oil-based lipid emulsion (SOLE) and to establish whether MOLE or SOLE is more effe...
What is the current status of trial NCT06915441?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 230 participants. The study started on 2026-05-01. Estimated completion is 2030-12-31.
What interventions are being tested in trial NCT06915441?
The interventions under investigation include: SOLE (DRUG), MOLE (DRUG).
Who is sponsoring clinical trial NCT06915441?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.